A Simple Computational Tool for Accurate, Quantitative Prediction of One–Electron Reduction Potentials of Hypoxia–Activated Tirapazamine Analogues
The reduction potentials of bioreductively-activated drugs represent an important design parameter to be accommodated in the course of creating lead compounds and improving the efficacy of older generation drugs. Reduction potentials are traditionally reported as single–electron reduction potential...
Main Authors: | Hassan RH Elsaidi, Leonard I Wiebe, Piyush Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30602 |
Similar Items
-
Development of [131I]I-EOE-TPZ and [131I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
by: Hassan Elsaidi, et al.
Published: (2019-01-01) -
Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers
by: Giimel Ajnai, et al.
Published: (2022-04-01) -
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma
by: Abi-Jaoudeh N, et al.
Published: (2021-05-01) -
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
by: Chris P. Guise, et al.
Published: (2020-10-01) -
Tirapazamine-loaded CalliSpheres microspheres enhance synergy between tirapazamine and embolization against liver cancer in an animal model
by: Qing Li, et al.
Published: (2022-07-01)